Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020

Among patients with coronavirus disease (COVID-19), IgM levels increased early after symptom onset for those with mild and severe disease, but IgG levels increased early only in those with severe disease. A similar pattern was observed in a separate serosurveillance cohort. Mild COVID-19 should be i...

Full description

Bibliographic Details
Main Authors: William T. Hu, J. Christina Howell, Tugba Ozturk, Karima Benameur, Leda C. Bassit, Richard Ramonell, Kevin S. Cashman, Shama Pirmohammed, John D. Roback, Vincent C. Marconi, Irene Yang, Valerie V. Mac, Daniel Smith, Ignacio Sanz, Whitney Wharton, F. Eun-Hyung Lee, Raymond F. Schinazi
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2020-12-01
Series:Emerging Infectious Diseases
Subjects:
Online Access:https://wwwnc.cdc.gov/eid/article/26/12/20-3334_article
_version_ 1818523335449903104
author William T. Hu
J. Christina Howell
Tugba Ozturk
Karima Benameur
Leda C. Bassit
Richard Ramonell
Kevin S. Cashman
Shama Pirmohammed
John D. Roback
Vincent C. Marconi
Irene Yang
Valerie V. Mac
Daniel Smith
Ignacio Sanz
Whitney Wharton
F. Eun-Hyung Lee
Raymond F. Schinazi
author_facet William T. Hu
J. Christina Howell
Tugba Ozturk
Karima Benameur
Leda C. Bassit
Richard Ramonell
Kevin S. Cashman
Shama Pirmohammed
John D. Roback
Vincent C. Marconi
Irene Yang
Valerie V. Mac
Daniel Smith
Ignacio Sanz
Whitney Wharton
F. Eun-Hyung Lee
Raymond F. Schinazi
author_sort William T. Hu
collection DOAJ
description Among patients with coronavirus disease (COVID-19), IgM levels increased early after symptom onset for those with mild and severe disease, but IgG levels increased early only in those with severe disease. A similar pattern was observed in a separate serosurveillance cohort. Mild COVID-19 should be investigated separately from severe COVID-19.
first_indexed 2024-12-11T05:43:43Z
format Article
id doaj.art-e763d22d1815415ea1ca5c5f3ff79d91
institution Directory Open Access Journal
issn 1080-6040
1080-6059
language English
last_indexed 2024-12-11T05:43:43Z
publishDate 2020-12-01
publisher Centers for Disease Control and Prevention
record_format Article
series Emerging Infectious Diseases
spelling doaj.art-e763d22d1815415ea1ca5c5f3ff79d912022-12-22T01:19:03ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592020-12-0126122974297810.3201/eid2612.203334Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020William T. HuJ. Christina HowellTugba OzturkKarima BenameurLeda C. BassitRichard RamonellKevin S. CashmanShama PirmohammedJohn D. RobackVincent C. MarconiIrene YangValerie V. MacDaniel SmithIgnacio SanzWhitney WhartonF. Eun-Hyung LeeRaymond F. SchinaziAmong patients with coronavirus disease (COVID-19), IgM levels increased early after symptom onset for those with mild and severe disease, but IgG levels increased early only in those with severe disease. A similar pattern was observed in a separate serosurveillance cohort. Mild COVID-19 should be investigated separately from severe COVID-19.https://wwwnc.cdc.gov/eid/article/26/12/20-3334_article2019 novel coronavirus diseasecoronavirus diseaseCOVID-19severe acute respiratory syndrome coronavirus 2SARS-CoV-2viruses
spellingShingle William T. Hu
J. Christina Howell
Tugba Ozturk
Karima Benameur
Leda C. Bassit
Richard Ramonell
Kevin S. Cashman
Shama Pirmohammed
John D. Roback
Vincent C. Marconi
Irene Yang
Valerie V. Mac
Daniel Smith
Ignacio Sanz
Whitney Wharton
F. Eun-Hyung Lee
Raymond F. Schinazi
Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020
Emerging Infectious Diseases
2019 novel coronavirus disease
coronavirus disease
COVID-19
severe acute respiratory syndrome coronavirus 2
SARS-CoV-2
viruses
title Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020
title_full Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020
title_fullStr Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020
title_full_unstemmed Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020
title_short Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020
title_sort antibody profiles according to mild or severe sars cov 2 infection atlanta georgia usa 2020
topic 2019 novel coronavirus disease
coronavirus disease
COVID-19
severe acute respiratory syndrome coronavirus 2
SARS-CoV-2
viruses
url https://wwwnc.cdc.gov/eid/article/26/12/20-3334_article
work_keys_str_mv AT williamthu antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020
AT jchristinahowell antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020
AT tugbaozturk antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020
AT karimabenameur antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020
AT ledacbassit antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020
AT richardramonell antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020
AT kevinscashman antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020
AT shamapirmohammed antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020
AT johndroback antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020
AT vincentcmarconi antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020
AT ireneyang antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020
AT valerievmac antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020
AT danielsmith antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020
AT ignaciosanz antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020
AT whitneywharton antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020
AT feunhyunglee antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020
AT raymondfschinazi antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020